71 /100
HIGH RISK
Score updated May 30, 2026

ENLV — Enlivex Ltd. Dilution Risk Tracker

Track ENLV dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ENLV — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
95
📊 Float Risk
52
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
42%
🔄 Reverse Split 55%
• 50-day avg $0.86 below $1 exchange minimum
📉 Score Deterioration 50%
• Score rose 45 points recently (worsening)
• Score in HIGH risk zone (71/100)
🔔 Track ENLV — Get forecast alerts →

💹 Market Data

Market Cap$195.32M
Shares Outstanding241.05M
Float57.72M
Cash$5.75M
Debt$641.0K
Short InterestN/A

🏛 Institutional Holdings

10 institutional holders · 1.23M shares
#1 Renaissance Technologies, LLC 313.6K shares
#2 Morgan Stanley 200.6K shares
#3 Two Sigma Investments, LP 195.1K shares
+ 7 more holders Sign up free to view →

📉 Short Interest

Short Interest407.5K
Days to Cover1.7
% of Float0.7%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2013
13F-HR BENEFICIAL OWNERSHIP Dec 31, 2025
13F-HR BENEFICIAL OWNERSHIP Dec 31, 2025
13F-HR BENEFICIAL OWNERSHIP Dec 31, 2025
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track ENLV Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ENLV — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for ENLV
📊 ENLV FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 ENLV Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.